Sign In
Buy CRON
$2.69
+0.0400 (+1.51%)
At Close: Jun 23, 2026
Cronos Group Inc. Announces Results of 2026 Annual Meeting of Shareholders
05:30pm, Monday, 22'nd Jun 2026
TORONTO, June 22, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Thursday,
3 Marijuana Stocks Investors Can See Returns On Before The End Of The Year
01:26pm, Wednesday, 17'th Jun 2026
A lot is going on in the cannabis industry between the USA and Canadian markets. As more people and companies prepare for the road ahead with the rescheduling of cannabis. This has put a lot of pressu
Cronos Announces Extension of Share Repurchase Program to the Toronto Stock Exchange
04:15pm, Tuesday, 16'th Jun 2026
TORONTO, June 16, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (“Cronos” or the “Company”) (NASDAQ: CRON) (TSX: CRON), an innovative global cannabis company, announced today that it has filed
Spinach® is the Number One Vape Brand in Canada
07:30am, Thursday, 11'th Jun 2026
Spinach® vapes, known for exceptional quality, bold flavor profiles and advanced hardware, continue to resonate with adult consumers across Canada Spinach® vapes, known for exceptional quality, bold
3 Canadian Marijuana Stocks That Could Help You Make Money
11:35am, Wednesday, 03'rd Jun 2026
Those who have been investing in marijuana stocks over the years have seen many changes. If you have been investing and trading since just before the pandemic, then you know how exciting the sector ca
Top Canadian Marijuana Stock Choices For Better Investing In 2026
10:53am, Friday, 22'nd May 2026
Many marijuana stock investors have a strong positive outlook on the future of the market. If you've been watching the cannabis sector, then you know how volatile and uncertain trading can be. Yet the
Cronos: Strong Q1 Earnings Driven By International Cannabis Sales
10:03pm, Thursday, 14'th May 2026
Cronos reported strong Q1 performance with record level revenue. International sales are driving growth and the Canadian markets are showing improvement. The company is set to acquire CanAdelaar in th
Cronos: Excellent M&A And Favorable Valuation Make This A Buy (Upgrade)
11:39am, Wednesday, 13'th May 2026
Cronos Group Inc. reported Q1 '26 revenue up 40% to $45 million, exceeding estimates. Despite strong top-line growth, CRON posted a small operating loss of $1.8 million, with net income driven by inte
Cronos Group Inc. (CRON:CA) Q1 2026 Earnings Call Transcript
08:50pm, Monday, 11'th May 2026
Cronos Group Inc. (CRON:CA) Q1 2026 Earnings Call Transcript
Cronos Group Q1 Earnings Call Highlights
10:09am, Monday, 11'th May 2026
Cronos Group NASDAQ: CRON reported record first-quarter 2026 net revenue and gross profit, with management pointing to growth in Israel, gains for its Spinach brand in Canada and continued internation
Cronos Group (CRON) Q1 Earnings Meet Estimates
09:45am, Monday, 11'th May 2026
Cronos Group (CRON) came out with quarterly earnings of $0.01 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.02 per share a year ago.
Cronos Group Reports 2026 First Quarter Results
07:30am, Monday, 11'th May 2026
Net revenue in Q1 2026 increased by 40% year-over-year to $45.2 million Achieved record net revenue and gross profit in Q1 2026 Reached #1 market share in vapes in Canada 1 Ninth consecutive quarter
Cronos Expands Pre-Roll Portfolio with Spinach STIX®
07:30am, Wednesday, 06'th May 2026
TORONTO, May 06, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, announced today that Spinach STIX®, its latest innovation
Cronos Group Inc. to Hold Virtual 2026 Annual Meeting of Shareholders
07:30am, Wednesday, 29'th Apr 2026
TORONTO, April 29, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2026 Annual Meeting of Shareholders on Thursday, June 18, 202
Aurinia Pharmaceuticals (NASDAQ:AUPH) vs. Cronos Group (NASDAQ:CRON) Financial Comparison
01:12am, Monday, 27'th Apr 2026
Aurinia Pharmaceuticals (NASDAQ: AUPH - Get Free Report) and Cronos Group (NASDAQ: CRON - Get Free Report) are both medical companies, but which is the better investment? We will compare the two compa
